Hubacek JA - Search Results

1

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D; DIAGRAM Consortium; MAGIC Consortium; InterAct Consortium; Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Pate… See abstract for full author list ➔ Swerdlow DI, et al. Among authors: hubacek ja. Lancet. 2015 Jan 24;385(9965):351-61. doi: 10.1016/S0140-6736(14)61183-1. Epub 2014 Sep 24. Lancet. 2015. PMID: 25262344 Free PMC article.

2

(TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolaemia.

Hubacek JA, Pistulková H, Valenta Z, Poledne R. Hubacek JA, et al. Vasa. 1999 Aug;28(3):169-71. doi: 10.1024/0301-1526.28.3.169. Vasa. 1999. PMID: 10483321

3

Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster.

Waterworth DM, Hubacek JA, Pitha J, Kovar J, Poledne R, Humphries SE, Talmud PJ. Waterworth DM, et al. Among authors: hubacek ja. J Lipid Res. 2000 Jul;41(7):1103-9. J Lipid Res. 2000. PMID: 10884292 Free article.

4

Genetic determination of plasma lipids and insulin in the Czech population.

Hubacek JA, Waterworth DM, Poledne R, Pitha J, Skodová Z, Humphries SE, Talmud PJ. Hubacek JA, et al. Clin Biochem. 2001 Mar;34(2):113-8. doi: 10.1016/s0009-9120(01)00184-9. Clin Biochem. 2001. PMID: 11311220

5

Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in the Czech population.

Hubácek JA, Waterworth DM, Pitha J, Humphries SE, Talmud PJ, Poledne R. Hubácek JA, et al. Physiol Res. 2001;50(4):345-51. Physiol Res. 2001. PMID: 11551139 Free article.

6

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Pennacchio LA, et al. Among authors: hubacek ja. Hum Mol Genet. 2002 Nov 15;11(24):3031-8. doi: 10.1093/hmg/11.24.3031. Hum Mol Genet. 2002. PMID: 12417524

7

Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study.

Hubacek JA, Pitha J, Skodová Z, Poledne R, Lánská V, Waterworth DM, Humphries SE, Talmud PJ; Czech MONICA Study. Hubacek JA, et al. Clin Biochem. 2003 Jun;36(4):263-7. doi: 10.1016/s0009-9120(03)00025-0. Clin Biochem. 2003. PMID: 12810154

8

Apolipoprotein E Arg136 --> Cys mutation and hyperlipidemia in a large central European population sample.

Hubacek JA, Adamková V, Stavek P, Kubinova R, Peasey A, Pikhart H, Marmot M, Bobak M. Hubacek JA, et al. Clin Chim Acta. 2008 Feb;388(1-2):217-8. doi: 10.1016/j.cca.2007.10.009. Clin Chim Acta. 2008. PMID: 18326082 No abstract available.

9

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.

Hubacek JA, Wang WW, Skodová Z, Adámková V, Vráblík M, Horínek A, Stulc T, Ceska R, Talmud PJ. Hubacek JA, et al. Clin Chem Lab Med. 2008;46(6):773-7. doi: 10.1515/CCLM.2008.160. Clin Chem Lab Med. 2008. PMID: 18601597

10

Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.

Dorfmeister B, Zeng WW, Dichlberger A, Nilsson SK, Schaap FG, Hubacek JA, Merkel M, Cooper JA, Lookene A, Putt W, Whittall R, Lee PJ, Lins L, Delsaux N, Nierman M, Kuivenhoven JA, Kastelein JJ, Vrablik M, Olivecrona G, Schneider WJ, Heeren J, Humphries SE, Talmud PJ. Dorfmeister B, et al. Among authors: hubacek ja. Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1866-71. doi: 10.1161/ATVBAHA.108.172866. Epub 2008 Jul 17. Arterioscler Thromb Vasc Biol. 2008. PMID: 18635818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters